Background: The evolution and spread of antimicrobial resistance is a major global public health threat. In some
4
bacteria; instead such studies have focused on the identification of new genes or the associations between drugs and resistance genes (e.g. [13, 14] ).
Here we describe a novel systems-level approach for the exploration of collateral closely related species, Mycobacterium smegmatis and Mycobacterium bovis, was obtained from multiple sources [7, 15] . A full list of genes used in this study can be found in Supp. Table S1 .
Genes implicated in resistance to classical TB drugs
We compiled a list of 40 genes implicated in classical TB drug resistance (hereafter termed DR genes) from The Tuberculosis Drug Resistance Mutation Database (https://tbdreamdb.ki.se/CMS/Download.aspx) (Supp. Table   S2 ). These included genes associated with resistance to rifampicin (RIF, n = 2), isoniazid (INH, n = 22), aminoglycosides (AMI, kanamycin/captromycin/amikacin/viomycin, n = 2), streptomycin (SM, n = 3), fluoroquinolones (FLQ, n = 2), ethambutol (EMB, n = 13), ethionamide (ETH, n = 3), para-aminosalisylic acid (PAS, n = 1) and pyrazinamide (PZA, n = 1).
Expression data
Mtb microarray gene expression data were obtained from sample series GSE1642 [16] from the NCBI GEO database. Data were available for Mtb exposed to 437 treatments, including the following in vitro treatment conditions: classical TB drugs as single agents (isoniazid, rifampicin, amikacin, streptomycin, levofloxacin, ofloxacin, ethambutol, ethionamide, pyrazinamide) and control conditions (7H9-based growth medium without drug treatment).
We assessed the impact of classical trug treatment by comparing the variance of expression of β -lactam s genes to that across all genes. Significance testing was performed by comparison to the null distribution generated by random subsampling of Mtb genes (n = 111 genes with 10,000 replicates), and counting the number of times we obtained a variance equal or greater than the observed value. Differential expression analysis was performed We assessed the significance of the interactions between gene sets (β-lactam S and DR genes) using BinoX [22] a method for estimating the distribution of crosstalk expected under a random model of a given network. In this study, distribution parameters are estimated under two different permutation procedures: permutation of the node labels or edges (denoted 'node swap' and 'link swap' respectively). Once the crosstalk distribution for the given gene set(s) has been estimated, the significance of an observed degree of crosstalk can be computed. In this study, 1000 permutations were used for both methods, and significance was corrected using Benjamini-Hochberg (and hence is reported as q-values).
Random network walks to identify

β -lactam S nodes influenced by DR nodes
We performed random walks between all pairs of nodes in the PPI and the GR networks separately to determine the access times as an indicator for the influence of one node over another. Random walks correspond to the possible paths taken by a random walker on a network between a pair of nodes. Access times represent the ease with which information (e.g. signal transduction, gene regulation) flows from one node to another, as it is proportional to the number of connections and available paths between nodes. Simulating the random walk was unnecessary as the access time on a finite graph has an analytical solution [23] computed via eigenvalue decomposition of the edge matrices of the networks. Fig. 2 ). These DR genes were disproportionately associated with INH resistance (10 genes) or to resistance to multiple drugs (7 genes), suggesting that these DR genes likely exert a strong regulatory influence on genes associated with β -lactam sensitivity.
Overall, DR and β -lactam s genes were found to be highly co-expressed in the transcriptional network of TB, supporting our hypothesis of a co-regulatory association of these genes in Mtb. suggest that the combined PPI and GR network was not drawn from a power-law distribution (p = 0.065, i.e.
indicating that we cannot reject the null hypothesis that the degree distribution follows a power-law distribution), supporting the view that the network structure is consistent with a true biological network [30]).
We found that the majority of β -lactam S nodes (47 of 57) were localized in a highly specific network region (shown in Fig. 3 ). Network analysis using link and node permutation in BinoX revealed that Since the importance of a node highly depends on the underlying network structure, we first determined how the structural differences between the PPI and GR networks would affect the random walks. We considered both directions of information flow, from DR nodes to To ensure that the set of gene pairs with smallest access times was biologically meaningful, we compared the co- Fig. 6A, B) , suggesting synthetic lethality and functional dependency between these genes. Of note, we found synthetic lethality between each of the sigC, atpH and blaI genes with the key DR genes embB, katG and furA (Fig. 6C) .
In silico functional validation of a dependence mechanism between
Discussion
Here we demonstrate a novel systems biology approach to the investigation of Mtb β -lactam collateral sensitivity.
We combined gene expression and network analyses and show that the inhibitor of intrinsic Our results suggest that blaI, together with its downstream targets, atpH and sigC, is a key regulator of collateral sensitivity resulting from classical drug resistance, although we were not able to detect a direct effect on Consequently, it will be essential to continue to develop our understanding of this phenomenon such that we can readily identify strains and therefore patients for whom ).
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Knockouts resulting in cells with a growth rate < 0.010 were considered as lethal (blue), and above this cutoff, non-lethal (red). C. 
